Ansicht Themen Nachrichten

BPI’s Submission to the EC call for Evidence for a Critical Medicines Act

The German Pharmaceutical Industry Association (BPI) supports the European Commission’s initiative to create a strong framework that enhances patient access to medicines while ensuring the European pharmaceutical industry’s competitiveness and resilience by fostering and supporting European production.